NuBloom Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.6/10
Best for: a physician-founded, whole-person GLP-1 and hormone program
NuBloom stands out for its medical oversight and the pharmacy behind it.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
NuBloom is a women's metabolic-health telehealth practice founded by family and integrative-medicine physician Dr. Marianne Pinkston Mueller, offering compounded GLP-1 therapy alongside hormone, gut-health and longevity care. Compounded semaglutide starts at $149/month and compounded tirzepatide at $279/month, billed as month-to-month subscriptions with dose ladders shown openly; a 90-day guided program adds coaching for $599/month. Care is delivered through an affiliated, LegitScript-certified telehealth network across 49 states. Compounded medications are not FDA-approved.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to NuBloom
Brightmeds
Best for: compounded or brand GLP-1 bundled with TRT and peptides for men
Editorial score · methodology
Direct Meds
Best for: listed for disclosure only — see its FDA warning and BBB complaints first
Editorial score · methodology
Maximus
Best for: men seeking compounded GLP-1 alongside testosterone optimization
Editorial score · methodology
NuBloom at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Microdose tirzepatide
- Starting price
- $149/mo
- What's included
- Medication
- Availability
- 49 states
- FDA status
- No FDA warning letter on record
How we scored NuBloom
Each dimension is scored algorithmically from NuBloom’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.8/10At $149/mo, NuBloom runs about 12% below the $169 median for GLP-1 providers.
Effectiveness25%
7.8/10NuBloom offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.9/10Online intake and platform experience; 8 platform features disclosed.
Trust & Safety15%
8.5/10Key details fully confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.
Accessibility10%
8.0/10NuBloom treats patients in all 50 states.
Support10%
6.2/10Coaching/nutrition support offered.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this NuBloom review
Last checked August 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $149–$279/mo across 3 dose/plan tiers — checked August 2026
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with NuBloom
We walked NuBloom’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a secure medical intake form (a guided pathway is also offered).
- 2In the guided pathway, complete a personalized lab panel and review results with a provider.
- 3If approved, the prescription is sent to a regulated U.S. pharmacy.
- 4Medication is shipped to your door.
- Offers tirzepatide under a Weight & Metabolism section with physician-guided treatment options.
- No monthly prices are shown on the page; CTAs direct users to 'Explore your options' and 'Get started' without listing costs.
- Two pathways offered: a direct treatment route and a guided route that adds labs and a provider review.
- No support phone number or email listed; contact is via a form and a free-consultation button (HubSpot).
GLP-1 medications NuBloom offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Homepage/product page: '$149/mo ... Once-weekly GLP-1 Injections, month to month subscription.' Single monthly price with doses 0.25/0.5/1/1.7/2/2.4 mg listed; BMI 27+.
Product page: '$279/mo. Once-weekly GLP-1/GIP Injections, month-to-month subscription.' Doses 2.5/5/7.5/10/12.5/15 mg listed; BMI 27+.
Microdose Tirzepatide product page: '$249/mo ... Month to month subscription.'
Ready to get started?
Plans and promotions change often — check NuBloom's current pricing and active discounts before you decide.
What we like
- Transparent, openly published pricing: compounded semaglutide $149/mo and tirzepatide $279/mo as flexible month-to-month subscriptions
- Founded and medically led by a named physician (Dr. Marianne Pinkston Mueller, family/integrative medicine, 25+ years)
- Whole-person model pairs GLP-1s with hormone, gut-health and longevity care plus in-depth lab testing
- State coverage published openly: 49 states listed on the site (all except Mississippi)
- Optional 90-day 1:1 coaching program with weekly meetings and unlimited text support ($599/mo)
- Dose ladders shown up front (semaglutide 0.25–2.4 mg; tirzepatide 2.5–15 mg), plus a lower-cost microdose tirzepatide at $249/mo
- Care delivered through Telegra MD, a LegitScript-certified telehealth organization
Watch-outs
- Compounding pharmacy partners are not named anywhere on the site — a transparency gap
- NuBloom's own LegitScript/PCAB status is not displayed; only its telehealth partner is certified
- Compounded medications are not FDA-approved; one FAQ loosely calls them 'FDA-approved,' contradicting the product pages
- All sales are final and medical consult fees are non-refundable; no returns on prescription products
- Disputes go to binding individual arbitration; the Terms' governing-law state is left as an unfilled '[STATE]' placeholder
- Legal entity is listed only as 'NuBloom,' with no LLC/Inc. suffix or business address published
- Whether the consultation and shipping are bundled into the monthly price is not clearly stated
Is NuBloom worth it?
The short version of what NuBloom offers is a physician-founded, whole-person GLP-1 and hormone program. It runs $149/month — toward the affordable end of the category, so cost isn't the reason to look elsewhere. Coaching and follow-up are part of the package, not an upsell.
It offers a microdosing option. It also is physician-led and includes coaching or dietitian support.
How much NuBloom actually costs
Compounded semaglutide runs $149/month, compounded tirzepatide runs $279/month, and compounded tirzepatide runs $249/month.
That puts NuBloom below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
altRX (about $149/month) is one of the closest alternatives to weigh NuBloom against.
Medications: what NuBloom prescribes
NuBloom prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who NuBloom is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost — $149/month is below the roughly $169 median we track across the category.
- want coaching and follow-up built into the price already, instead of sold separately as an upsell.
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
NuBloom treats patients in all 50 states, and dispenses through an accredited compounding pharmacy, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
NuBloom earns its place on the shortlist mainly on price: at $149/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
NuBloom stands out for its medical oversight and the pharmacy behind it.
Ready to start with NuBloom?
Starting at $149/month. See current pricing and start your free consultation.
NuBloom might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this NuBloom review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See NuBloom's current pricing
Plans start at $149/month. Start your free consultation to check eligibility and today's price.